Definitive Contract HHSD200201794868C
Award Date
8/1/17
Potential Completion Date
7/31/22
Potential Value
$2.3M
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer. The $2,201,243.29 contract is for the storage and rotation of Pfizer vaccines. The contract has an ultimate completion date of July 31, 2027. This contract is not set aside for small businesses. Pfizer is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the CDC's broader efforts to...
This is a $37,190,000.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. The contract, which ran from July 1, 2016 to June 30, 2017, was for the 2016 Vaccine for Adults (VFA) program and did not have a set-aside designation. Pfizer, a global pharmaceutical corporation, served as the prime contractor and supplied a variety of pharmaceutical products and vaccines to support the CDC's healthcare initiatives. This included...
This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the...
This is a firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the supply of adult vaccines. The contract has a ceiling value of $54,499,343.31 and an ultimate completion date of June 30, 2016. The contract does not have a set-aside designation. Pfizer, the prime contractor, is a global pharmaceutical corporation that plays a significant role in supplying medical products and services to the U.S. federal government. This contract...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines for the years 2024-2025, with a contract ceiling value of $2,271.56. The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. The contract supports the federal government's ongoing COVID-19 vaccination efforts, providing 0.9 mL...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Definitive Contract to Pfizer Inc., a large pharmaceutical company, for the 2017 Vaccines for Children program. The contract has a potential value of $1,347,249,175.05 and a completion date of March 31, 2018. The contract does not have a set-aside designation. Under this award, Pfizer will provide a variety of pharmaceutical products and vaccines to support immunization programs...
This is a $1,100.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Pfizer COVID-19 vaccine doses to support healthcare requirements from 2024 to 2025, including an initial 6-month period and up to a 4-year extension. This order is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, with a ceiling value of $1,135.77, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the supply of 0.9 mL doses of the Pfizer COVID-19 vaccine over a period of 6 months to 4 years, with an ultimate completion date...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded Pfizer Inc., doing business as Pfizer, a $103,298.40 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule contract. Pfizer will provide COVID-19 (COMIRNATY) vaccines to the CDC from September 22, 2023 through October 31, 2023. The delivery order supports the CDC's ongoing efforts to purchase and distribute COVID-19 vaccines as part of its pandemic response...
This is a $4,866.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Pfizer COVID-19 vaccines with a delivery period from 2024 to 2025. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...